Chronic Periodontitis Microbiota in Type 2 Diabetes Mellitus Patients

December 21, 2018 updated by: Marco Montevecchi, University of Bologna

The Subgingival Microbiota in Chronic Periodontitis Patients Affected by Type 2 Diabetes Mellitus: a Retrospective Comparative Study

This study is a retrospective comparative evaluation of six main periodontal pathogens and total bacterial load in chronic periodontitis patients affected or not by type 2 diabetes mellitus by polymerase chain reaction analysis.

Study Overview

Detailed Description

The aim of this study was to compare prevalence and bacterial load of six main periodontal pathogens among chronic periodontitis patients with and without type 2 diabetes mellitus. Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans genotypes were also investigated.

The recruitment for the study sample was performed analysing the medical records of adult patients with chronic periodontitis visited between 2010 and 2016. Eligible patients were subdivided in two balanced groups on the basis of the presence or absence of type 2 diabetes mellitus at the time of the microbiological test.

For each subject, the following data have been collected: age, gender, smoking habits, type of metabolic control of diabetes, duration of diabetes, number of missing teeth.

For each subject, four periodontal sites were studied. Probing pocket depth, sites with bleeding on probing, sites with suppuration and microbiological data were evaluated.

An individual matching on the basis of severity and extension of periodontitis was performed by pairing a diabetic patient with another non-diabetic one with the same degree of severity and extension of the periodontal disease.

Microbiological data of subgingival biofilm were analysed and compared for the examined pathogens: Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, Fusobacterium nucleatum, Tannerella forsythia.

Differences in genotypes of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans among diabetic and non-diabetic patients were also evaluated.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bologna, Italy, 40120
        • Alma Mater Studiorum - University of Bologna, Department of Biomedical and Neuromotor Sciences, School of Dentistry - Division of Periodontology and Implantology.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The recruitment for the study sample was performed analysing the medical records of adult patients with chronic periodontitis visited between 2010 and 2016. Eligible patients were subdivided in two balanced groups on the basis of the presence or absence of type 2 diabetes mellitus at the time of the microbiological test.

Description

Inclusion Criteria:

  • diagnosis of chronic periodontitis
  • diagnosis of type 2 diabetes mellitus (only in the test group)
  • the presence of at least 12 teeth (except for the third molar)
  • belonging to caucasian ethnic group
  • age greater than 18 years.

Exclusion Criteria:

  • pregnant or lactating
  • history of systemic antibiotics within 3 months prior to the microbiological testing or anti-inflammatory therapy in the month before the visit
  • if they were suffering from any other systemic disease except diabetes mellitus (arthritis, ulcerative colitis, Crohn's disease, osteoporosis or osteopenia, HIV infection, hematologic diseases, neoplastic diseases, cardiovascular diseases or pathologies that could potentially interfere with the periodontitis and/or with diabetes)
  • mental disorders
  • if they had received periodontal treatment in the 6 months before the microbiological test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
type 2 diabetics
Analysis of microbiological tests in chronic periodontitis patients with type 2 diabetes mellitus
Collection and comparison of microbiological data
non-diabetics
Analysis of microbiological tests in chronic periodontitis patients without type 2 diabetes mellitus
Collection and comparison of microbiological data

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bacterial load of six main periodontal pathogens
Time Frame: November 16th 2016
Bacterial load mean of six main periodontal pathogens expressed as number after a polymerase chain reaction count
November 16th 2016
Prevalence of six main periodontal pathogens
Time Frame: November 16th 2016
Number of sites presenting a specific pathogen
November 16th 2016
Relative bacterial load of six main periodontal pathogens
Time Frame: November 16th 2016
A mean percentage that derives from the comparison of the bacterial load to the total bacterial load
November 16th 2016
Total bacterial load
Time Frame: November 16th 2016
A mean of all bacteria present in a periodontal site expressed as number after a polymerase chain reaction count
November 16th 2016

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Genotypes of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans
Time Frame: November 16th 2016
Genotypes of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans were compared
November 16th 2016

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Marco Montevecchi, DDS, University of Bologna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 10, 2016

Primary Completion (Actual)

July 26, 2016

Study Completion (Actual)

November 16, 2016

Study Registration Dates

First Submitted

December 14, 2018

First Submitted That Met QC Criteria

December 21, 2018

First Posted (Actual)

December 24, 2018

Study Record Updates

Last Update Posted (Actual)

December 24, 2018

Last Update Submitted That Met QC Criteria

December 21, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data will be available when the research will be published

IPD Sharing Time Frame

Data will be available when the research will be published

IPD Sharing Access Criteria

On request to the main investigator

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on Analysis of microbiological tests

Subscribe